Release Date: 22/03/18 16:45 Summary: Supplementary Bidders Statement Price Sensitive: No Download Document 1.32MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%